Citigroup’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.42M | Sell |
|
|||||
|
2025
Q2 | $3.38M | Buy |
|
|||||
|
2025
Q1 | $1.71M | Sell |
|
|||||
|
2024
Q4 | $2.77M | Buy |
|
|||||
|
2024
Q3 | $3.54M | Buy |
|
|||||
|
2024
Q2 | $3.37M | Buy |
|
|||||
|
2024
Q1 | $3.35M | Buy |
|
|||||
|
2023
Q4 | $3.45M | Buy |
|
|||||
|
2023
Q3 | $2.67M | Sell |
|
|||||
|
2023
Q2 | $2.7M | Buy |
|
|||||
|
2023
Q1 | $2.18M | Sell |
|
|||||
|
2022
Q4 | $1.87M | Buy |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $21K | Sell |
|
|||||
|
2022
Q1 | $124K | Sell |
|
|||||
|
2021
Q4 | $716K | Buy |
|
|||||
|
2021
Q3 | $506K | Sell |
|
|||||
|
2021
Q2 | $2.34M | Buy |
|
|||||
|
2021
Q1 | $634K | Buy |
|
|||||
|
2020
Q4 | $68K | Buy |
|
|||||
|
2020
Q3 | $12K | Sell |
|
|||||
|
2020
Q2 | $28K | Sell |
|
|||||
|
2020
Q1 | $30K | Buy |
|
|||||
|
2019
Q4 | $45K | Buy |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $72K | Sell |
|
|||||
|
2019
Q1 | $350K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $7K | Buy |
|
|||||
|
2015
Q4 | $13K | Buy |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $1K | Buy |
|